SCHEMBL17437430

SCHEMBL17437430

CCn1c(-n2ncnc2NC(C)=O)nc2cncc(-c3ccccc3C)c21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.40
CYP1A2 P05177 6/20 0.38
CYP3A4 P08684 5/20 0.38
CYP2C9 P11712 3/20 0.38
HSD17B10 Q99714 2/20 0.38
ALOX15 P16050 2/20 0.38
TSHR P16473 2/20 0.38
HTT P42858 2/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RPS6KA5 O75582 1/20 0.33
CYP2C19 P33261 4/20 0.33
KMT2A Q03164 2/20 0.33
LYN P07948 1/20 0.33
SRC P12931 1/20 0.33
BTK Q06187 1/20 0.33
MEN1 O00255 1/20 0.33
KDM4E B2RXH2 1/20 0.32
CYP2D6 P10635 3/20 0.32
RIPK1 Q13546 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437551 0.86 POLB (0.36) POLBCYP3A4CYP2C9HTTSMN1; SMN2
SCHEMBL16053847 0.81 RPS6KA5 (0.36) CYP1A2CYP3A4HSD17B10ALOX15TSHR
SCHEMBL17437453 0.74 RPS6KA5 (0.35) RPS6KA5NUDT1
SCHEMBL17437460 0.71 RPS6KA5 (0.34) CYP1A2HTTRPS6KA5LYNSRC
SCHEMBL17437576 0.70 HTR2C (0.35) CYP1A2HSD17B10TSHRHTTRPS6KA5
SCHEMBL17437415 0.70 CYP1A2 (0.32) CYP1A2CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL17437329 0.69 EGFR (0.38) CYP1A2HTTRPS6KA5CYP2D6
SCHEMBL17437565 0.69 TLR8 (0.35) CYP1A2RPS6KA5KDM4EL3MBTL1
SCHEMBL17437323 0.69 RPS6KA5 (0.34) RPS6KA5KDM4E
SCHEMBL17437422 0.67 KDM4E (0.42) CYP1A2CYP2C9LMNASMN1; SMN2RPS6KA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 US disclosed
US-9512120-B2 Microbicidally active imidazopyridine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2016-12-06 US disclosed
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 POLB 1804/4885CYP1A2 25/4885CYP3A4 59/4885
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 POLB 1804/4885CYP1A2 25/4885CYP3A4 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.